What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Genome-wide association study, Genetics, Single-nucleotide polymorphism, Case-control study and Internal medicine.
His Genome-wide association study study combines topics in areas such as Cancer, Disease, Genetic association and Locus.
His research in Single-nucleotide polymorphism intersects with topics in Genotyping, Prostate cancer, Allele and Bioinformatics.
His Case-control study study incorporates themes from Odds ratio, Lung cancer, Epidemiology and Risk factor.
His Internal medicine research is multidisciplinary, relying on both Immunology, Endocrinology and Oncology.
He has researched Breast cancer in several fields, including TOX3 and Genetic predisposition.
His most cited work include:
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk (834 citations)
- Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies (782 citations)
- Multiple newly identified loci associated with prostate cancer susceptibility. (754 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Oncology, Genome-wide association study, Case-control study and Prostate cancer.
Breast cancer, Odds ratio, Prospective cohort study, Cancer and Cohort are among the areas of Internal medicine where he concentrates his study.
His studies deal with areas such as Gynecology, Cohort study, DNA methylation and Risk factor as well as Oncology.
His work deals with themes such as Allele and Genetic association, which intersect with Genome-wide association study.
His Case-control study research is multidisciplinary, incorporating perspectives in Endocrinology and Epidemiology.
His Prostate cancer research incorporates themes from Prostate and Family history.
He most often published in these fields:
- Internal medicine (85.37%)
- Oncology (67.81%)
- Genome-wide association study (49.05%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (85.37%)
- Oncology (67.81%)
- Cohort (23.06%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Oncology, Cohort, Prospective cohort study and Case-control study.
Odds ratio, Breast cancer, Cancer, Cohort study and European Prospective Investigation into Cancer and Nutrition are the primary areas of interest in his Internal medicine study.
The concepts of his Oncology study are interwoven with issues in Genome-wide association study, Epidemiology, DNA methylation and Prostate cancer.
His research integrates issues of Pancreatic cancer, Carcinoma, Allele, Genetic association and Computational biology in his study of Genome-wide association study.
As a member of one scientific family, Gianluca Severi mostly works in the field of Cohort, focusing on Incidence and, on occasion, Renal cell carcinoma.
His Case-control study study integrates concerns from other disciplines, such as Young adult, Single-nucleotide polymorphism, Ovarian cancer and Cotinine.
Between 2017 and 2021, his most popular works were:
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (85 citations)
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (85 citations)
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (85 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Gianluca Severi mainly focuses on Internal medicine, Oncology, Prospective cohort study, Cohort and Genome-wide association study.
His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Taurocholic acid, Taurochenodeoxycholic acid and Taurodeoxycholic acid.
His Oncology research is multidisciplinary, incorporating elements of Cancer, Colorectal cancer, Methylation and DNA methylation.
His biological study focuses on Breast cancer.
His Genome-wide association study study is associated with Genotype.
Gianluca Severi focuses mostly in the field of Case-control study, narrowing it down to topics relating to Single-nucleotide polymorphism and, in certain cases, Vitamin B12.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
